Digital Innovation Is Essential to Meeting Healthcare Consumers’ Expectations Post-Pandemic, According to Accenture Report

NEW YORK; June 21, 2021 – Senior healthcare executives say that moving to the cloud is among their top priorities as they reimagine how their organizations provide healthcare services to meet consumers’ evolving expectations post-pandemic, according to a new report from Accenture (NYSE: ACN).  
June 21, 2021

“New Science” is Driving More Growth than Predicted Against a Changing Economic Environment, According to Accenture Report

NEW YORK; June 1, 2021 – The adoption of New Science – a unique combination of the best in science and health technology that address significant unmet patient needs – is delivering more precise and effective treatments, but often at a higher price tag, according to new research from Accenture (NYSE: ACN).
June 01, 2021

Accenture Named a Leader in Everest Group’s Veeva PEAK Services Matrix Assessment 2021

NEW YORK; May 3, 2021 – Accenture (NYSE: ACN) has been named a leader in Everest Group’s Veeva PEAK Services Matrix® Assessment 2021 report.
May 03, 2021

Accenture Accelerates Mankind Pharma’s Digital Transformation with Data-Driven Cloud Platform

NEW DELHI; May 3, 2021 – Mankind Pharma, the fourth largest pharmaceutical manufacturing company headquartered in India, has collaborated with Accenture (NYSE: ACN) to accelerate its digital transformation journey to become an intelligent enterprise, improving business agility, performance, and operational efficiency.
May 03, 2021

Kaiser Permanente Accelerates its Use of Cloud in Strategic Collaboration with Accenture and Microsoft

NEW YORK and REDMOND, Wash.; Feb. 3, 2021 Kaiser Permanente is collaborating with Accenture (NYSE: ACN) and Microsoft Corp. (NASDAQ: MSFT) to enhance its innovative, scalable hosted cloud environment that supports its 12.4 million members and more than 85,000 clinicians. Together, these three companies will accelerate Kaiser Permanente’s journey to improve their cloud capabilities.
February 03, 2021

Accenture Recognized as the Leading Global Service Provider to the Healthcare Industry

NEW YORK; Jan. 18, 2021 – Accenture (NYSE: ACN) has been named the number one service provider for the healthcare sector in a recent report from industry analyst firm HFS Research.
January 18, 2021

Medable Named Life Sciences Innovation Champion in the Accenture HealthTech Innovation Challenge

NEW YORK; Dec. 16, 2020 – Medable has been named the Accenture HealthTech Innovation Challenge – Life Sciences Innovation Champion for providing patients with an integrated digital and physical experience during clinical trials, allowing them to access clinical care sites and clinical trial teams from their mobile phones. Medable was one of five finalists invited to pitch their innovative solutions to a panel of life sciences leaders during a virtual event held earlier this week.
December 16, 2020

Accenture Recognized as a Leading Provider of Financial Improvement Services to Healthcare Industry

NEW YORK; Dec. 9, 2020 – Accenture (NYSE: ACN) has been named a leading provider of financial improvement consulting services to healthcare organizations in a recent report from industry analyst firm KLAS Research, receiving a ranking of 94.7 out of 100.
December 09, 2020

Accenture, Orexo Team to Offer Digital Therapeutics Through INTIENT™ Platform

NEW YORK and MORRISTOWN, N.J.; Nov. 16, 2020 ‒ Accenture (NYSE: ACN) has helped the U.S. subsidiary of Swedish pharmaceutical company Orexo launch its first digital therapeutic, vorvida®, for patients in the United States dealing with problematic alcohol use. vorvida® is a web-based digital platform that uses the INTIENT™ Patient solution suite, which is powered by Google Cloud, to enable secure patient interactions and connectivity to an ecosystem of third-party health care services.
November 16, 2020

Accenture and Tokyo Women’s Medical University to Conduct Joint Research on Potential Benefits of Artificial Intelligence for Kidney Transplant Treatment

TOKYO; Nov. 5, 2020 – Accenture (NYSE:ACN) and Tokyo Women’s Medical University (TWMU) have agreed to conduct joint research using artificial intelligence (AI) to verify and analyze kidney transplant test results, recognize early-stage kidney transplant rejection tendencies and to foresee side effects in efforts to identify more effective post-operation treatments for patients.
November 04, 2020